All Curated Mutation Sites in CHIKV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in CHIKV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
6K
  
C
  
E1
  
E2
  
E3
  
nsP1
  
nsP2
  
nsP3
  
nsP4
  
Pol
  

Keyword: Chikungunya Fever-35208808
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 35208808 A226V
E1
E1
Chikungunya Fever
G
R
L
View
2 35208808 K211E
E1
E1
Chikungunya Fever
G
R
L
View
3 35208808 V264A
E2
E2
Chikungunya Fever
G
R
L
View
4 35208808 K73R
C
Capsid
Chikungunya Fever
R
L
View
5 35208808 N79S
C
Capsid
Chikungunya Fever
R
L
View
6 35208808 I317V
E1
E1
Chikungunya Fever
R
L
View
7 35208808 I344M
E1
E1
Chikungunya Fever
R
L
View
8 35208808 A76T
E2
E2
Chikungunya Fever
R
L
View
9 35208808 M74I
E2
E2
Chikungunya Fever
R
L
View
10 35208808 Q146R
E2
E2
Chikungunya Fever
R
L
View
11 35208808 T23S
E3
E3
Chikungunya Fever
R
L
View
12 35208808 R171Q
nsP1
nsP1
Chikungunya Fever
R
L
View
13 35208808 V139I
nsP1
nsP1
Chikungunya Fever
R
L
View
14 35208808 E145D
nsP2
nsP2
Chikungunya Fever
R
L
View
15 35208808 H130Y
nsP2
nsP2
Chikungunya Fever
R
L
View
16 35208808 N495S
nsP2
nsP2
Chikungunya Fever
R
L
View
17 35208808 V793I
nsP2
nsP2
Chikungunya Fever
R
L
View
18 35208808 L500S
nsP4
nsP4
Chikungunya Fever
R
L
View
19 35208808 S55N
nsP4
nsP4
Chikungunya Fever
R
L
View
Contents
Description

The table shows all curated mutation sites of CHIKV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.